Compound 9i(Shiraz University of Medical Sciences)

A series of novel aryl-substituted aminomethyl 1,2,3-triazole–cinamamide hybrids (9a–q) were synthesized and tested as tyrosinase inhibitors using enzymatic, in silico, and cell-based assays.